Report cover image

Global Anti-Suicide Drugs Market -Global Trends and Forecasts(2025 to 2034)

Publisher Factview Research
Published Nov 02, 2025
Length 102 Pages
SKU # FAVR20572923

Description

Anti-Suicide Drugs Market Size And Forecast

According to Factview Research, The Global Anti-Suicide Drugs Market was valued at USD 3.76 Billion in 2024 and is projected to reach USD 5.45Million by 2034, growing at a CAGR of 4.2% from 2025 to 2034.

Global Anti-Suicide Drugs Market Outlook

One of the major driving factors for the market is the increasing suicidal rates around the globe. According to WHO, out of the total deaths that happened in 2017, around 1-1.5% accounted for suicides. Other factors contributing to the growth of the market are rising awareness about good mental health, changing, increased focus on research and development leading to the launch of novel anti-suicidal drugs. However, lack of effective therapies, abusive used of drugs leading to addiction and rising adoption of unapproved therapies are likely to cause hindrance in the market growth over the forecast period.

Global Anti-Suicide Drugs Market Competitive Landscape

The Global Anti-Suicide Drugs Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Pfizer, Inc., Johnson & Johnson, Eli Lilly, and Company, Allergan plc, GlaxoSmithkline plc, AstraZeneca plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc..

Table of Contents

102 Pages
1 Introduction Of Global Anti-suicide Drugs Market
1.1 Overview Of The Market
1.2 Scope Of Report
1.3 Assumptions
2 Executive Summary
3 Research Methodology Of Factview Research
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List Of Data Sources
4 Global Anti-suicide Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 Global Anti-suicide Drugs Market, By Drug Class
5.1 Overview
5.2 Anti-depressant And Anti-anxiety Drugs
5.3 N-methyl-d-aspartate (Nmda) Receptor Antagonists
5.4 Antibiotic Analog
5.5 Anti-psychotic Drugs
5.6 Others
6 Global Anti-suicide Drugs Market, By Distribution Channel
6.1 Overview
6.2 Hospital Pharmacies
6.3 Retail Pharmacies
7 Global Anti-suicide Drugs Market, By Geography
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest Of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest Of Asia Pacific
7.5 Rest Of The World
7.5.1 Latin America
7.5.2 Middle East And Africa
8 Global Anti-suicide Drugs Market Competitive Landscape
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies
9 Company Profiles
9.1 Pfizer, Inc.
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Johnson &Amp; Johnson
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Eli Lilly And Company
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Allergan Plc
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Glaxosmithkline Plc
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Astrazeneca Plc
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Merck &Amp; Co., Inc.
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 H. Lundbeck A/S
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Neurorx, Inc.
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
10 Appendix
10.1 Related Reports

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us